Network Bio, which is developing an AI foundation model from datasets of patient tissue and blood samples created by pooling access to biobanks, raised $50M (Brian Gormley/Wall Street Journal)

Network Bio is building an AI foundation model that trains on pooled patient tissue and blood samples from multiple biobanks, aiming to accelerate drug discovery and diagnostics. The company secured $50 million in new financing to expand its data platform and model development.